Guidelines for the diagnosis and management of chylomicron retention disease based on a review of the literature and the experience of two centers. - Archive ouverte HAL Access content directly
Journal Articles Orphanet Journal of Rare Diseases Year : 2010

Guidelines for the diagnosis and management of chylomicron retention disease based on a review of the literature and the experience of two centers.

(1, 2, 3) , (4, 5) , (6) , (6) , (4, 5) , (2, 5) , (2, 3) , (5) , (2, 3) , (6) , (2, 3) , (1)
1
2
3
4
5
6
Claude Roy
  • Function : Author
  • PersonId : 916522
Colette Deslandres
  • Function : Author
  • PersonId : 916523
Lise Bouthillier
  • Function : Author
  • PersonId : 916527
Emile Levy
  • Function : Correspondent author
  • PersonId : 862567

Connectez-vous pour contacter l'auteur

Abstract

Familial hypocholesterolemia, namely abetalipoproteinemia, hypobetalipoproteinemia and chylomicron retention disease (CRD), are rare genetic diseases that cause malnutrition, failure to thrive, growth failure and vitamin E deficiency, as well as other complications. Recently, the gene implicated in CRD was identified. The diagnosis is often delayed because symptoms are nonspecific. Treatment and follow-up remain poorly defined.The aim of this paper is to provide guidelines for the diagnosis, treatment and follow-up of children with CRD based on a literature overview and two pediatric centers 'experience.The diagnosis is based on a history of chronic diarrhea with fat malabsorption and abnormal lipid profile. Upper endoscopy and histology reveal fat-laden enterocytes whereas vitamin E deficiency is invariably present. Creatine kinase (CK) is usually elevated and hepatic steatosis is common. Genotyping identifies the Sar1b gene mutation.Treatment should be aimed at preventing potential complications. Vomiting, diarrhea and abdominal distension improve on a low-long chain fat diet. Failure to thrive is one of the most common initial clinical findings. Neurological and ophthalmologic complications in CRD are less severe than in other types of familial hypocholesterolemia. However, the vitamin E deficiency status plays a pivotal role in preventing neurological complications. Essential fatty acid (EFA) deficiency is especially severe early in life. Recently, increased CK levels and cardiomyopathy have been described in addition to muscular manifestations. Poor mineralization and delayed bone maturation do occur. A moderate degree of macrovesicular steatosis is common, but no cases of steatohepatitis cirrhosis. Besides a low-long chain fat diet made up uniquely of polyunsaturated fatty acids, treatment includes fat-soluble vitamin supplements and large amounts of vitamin E. Despite fat malabsorption and the absence of postprandial chylomicrons, the oral route can prevent neurological complications even though serum levels of vitamin E remain chronically low. Dietary counseling is needed not only to monitor fat intake and improve symptoms, but also to maintain sufficient caloric and EFA intake. Despite a better understanding of the pathogenesis of CRD, the diagnosis and management of the disease remain a challenge for clinicians. The clinical guidelines proposed will helpfully lead to an earlier diagnosis and the prevention of complications.
Fichier principal
Vignette du fichier
1750-1172-5-24.pdf (1.71 Mo) Télécharger le fichier
Vignette du fichier
1750-1172-5-24.xml (102.75 Ko) Télécharger le fichier
Origin : Publisher files allowed on an open archive
Format : Other
Loading...

Dates and versions

inserm-00654377 , version 1 (21-12-2011)

Licence

Attribution - CC BY 4.0

Identifiers

Cite

Noel Peretti, Agnès Sassolas, Claude Roy, Colette Deslandres, Mathilde Charcosset, et al.. Guidelines for the diagnosis and management of chylomicron retention disease based on a review of the literature and the experience of two centers.. Orphanet Journal of Rare Diseases, 2010, 5 (1), pp.24. ⟨10.1186/1750-1172-5-24⟩. ⟨inserm-00654377⟩
233 View
231 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More